ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
North Terrace House,
19 North Terrace,
Hackney, SA, 5069
1300 128 339
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Cognitive Dysfunction In Chronic Fatigue Syndrome, Molecular Pattern Discovered
Thursday 12 January 2017
Cognitive dysfunction in chronic fatigue syndrome, molecular pattern discovered, hopes for improved diagnosis and treatment
A molecular pattern has been discovered with regards to cognitive dysfunction in chronic fatigue syndrome, giving hope for improved diagnosis and treatment. The researchers uncovered a unique pattern of immune molecules in the cerebrospinal fluid in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This discovery provides insight into the basis for cognitive dysfunction – also known as brain fog – and may inform advancements in the syndrome diagnosis and treatment.
The researchers measured the levels of 51 immune biomarkers called cytokines in cerebrospinal fluid of 32 ME/CFS patients, 40 multiple sclerosis patients, and 19 healthy controls. The researchers found that the levels of most cytokines were depressed in ME/CFS patients, compared to the other groups.
blog comments powered by Disqus